Ferrari-Souza, João Pedro;
Bellaver, Bruna;
Ferreira, Pâmela CL;
Benedet, Andréa L;
Povala, Guilherme;
Lussier, Firoza Z;
Leffa, Douglas T;
... Pascoal, Tharick A; + view all
(2023)
APOEε4 potentiates amyloid β effects on longitudinal tau pathology.
Nature Aging
, 3
pp. 1210-1218.
10.1038/s43587-023-00490-2.
Preview |
Text
Zetterberg_Ferrari.pdf Download (1MB) | Preview |
Abstract
The mechanisms by which the apolipoprotein E ε4 (APOEε4) allele influences the pathophysiological progression of Alzheimer's disease (AD) are poorly understood. Here we tested the association of APOEε4 carriership and amyloid-β (Aβ) burden with longitudinal tau pathology. We longitudinally assessed 94 individuals across the aging and AD spectrum who underwent clinical assessments, APOE genotyping, magnetic resonance imaging, positron emission tomography (PET) for Aβ ([18F]AZD4694) and tau ([18F]MK-6240) at baseline, as well as a 2-year follow-up tau-PET scan. We found that APOEε4 carriership potentiates Aβ effects on longitudinal tau accumulation over 2 years. The APOEε4-potentiated Aβ effects on tau-PET burden were mediated by longitudinal plasma phosphorylated tau at threonine 217 (p-tau217+) increase. This longitudinal tau accumulation as measured by PET was accompanied by brain atrophy and clinical decline. Our results suggest that the APOEε4 allele plays a key role in Aβ downstream effects on the aggregation of phosphorylated tau in the living human brain.
Archive Staff Only
 |
View Item |
